Published in Prostate on October 01, 1997
Fixed Size of Enlarged Calcified Lymph Nodes in Esophageal Adenocarcinoma despite Complete Remission. Case Rep Gastroenterol (2009) 0.77
Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapy. Ann Oncol (2007) 1.96
Induction of heme oxygenase-1 expression in macrophages by diesel exhaust particle chemicals and quinones via the antioxidant-responsive element. J Immunol (2000) 1.65
Influence of "diagnostic delay" upon cancer survival: an analysis of five tumour sites. J Epidemiol Community Health (1991) 1.41
Predictive modelling in hormone-refractory prostate cancer (HRPC). Clin Transl Oncol (2009) 1.40
[Experience with 150 subcutaneous venous reservoirs for venous access and infusion for the treatment of adult patients with oncologic and hematologic disorders and acquired immunodeficiency syndrome]. Med Clin (Barc) (1992) 1.40
Cancer survival and the duration of symptoms. An analysis of possible forms of the risk function. ISDS II Project Investigators. Eur J Cancer (1994) 1.25
Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver. J Hepatol (2000) 1.21
Osteonectin/SPARC is overexpressed in human hepatocellular carcinoma. J Pathol (1999) 1.17
Delta9-tetrahydrocannabinol induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism. FEBS Lett (1999) 1.11
Massive tumor implantation in the endoscopic resected area in modified nephroureterectomy. J Urol (1997) 1.08
Tumour CD133 mRNA expression and clinical outcome in surgically resected colorectal cancer patients. Eur J Cancer (2009) 1.08
Behavioral characterization and genetic analysis of the Drosophila melanogaster larval response to light as revealed by a novel individual assay. Behav Genet (2000) 1.04
Phase I-II study of paclitaxel, cisplatin, and gemcitabine in advanced transitional-cell carcinoma of the urothelium. Spanish Oncology Genitourinary Group. J Clin Oncol (2000) 0.99
Classification and scoring systems in myelodysplastic syndromes: a retrospective analysis of 311 patients. Leuk Res (2006) 0.99
Quantification and characterization of carotid calcium with multi-detector CT-angiography. Eur J Vasc Endovasc Surg (2006) 0.94
Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma. Ann Oncol (2003) 0.94
Local recurrence of low rectal cancer after abdominoperineal and anterior resection. Br J Surg (1997) 0.93
Emergency admission for cancer: a matter of survival? Br J Cancer (1998) 0.93
Comparison of three protracted antiemetic regimens for the control of delayed emesis in cisplatin-treated patients. Eur J Cancer (1992) 0.92
Prognostic time dependence of deletions affecting codons 557 and/or 558 of KIT gene for relapse-free survival (RFS) in localized GIST: a Spanish Group for Sarcoma Research (GEIS) Study. Ann Oncol (2010) 0.92
Prospective study of microscopic lymph node involvement of the hepatic pedicle during curative hepatectomy for colorectal metastases. Br J Surg (1996) 0.91
Liver retransplantation for alcoholic cirrhosis recurring within a 21-month period. Transpl Int (1996) 0.89
Progression from idiopathic portal hypertension to incomplete septal cirrhosis with liver failure requiring liver transplantation. J Hepatol (1995) 0.87
Nuclear beta-catenin in colorectal tumors: to freeze or not to freeze? Colon Cancer Team at IMAS. J Histochem Cytochem (1999) 0.87
Do we believe what patients say about their neoplastic symptoms? An analysis of factors that influence the interviewer's judgement. Eur J Epidemiol (1996) 0.87
Gemcitabine/paclitaxel-based three-drug regimens in advanced urothelial cancer. Eur J Cancer (2000) 0.85
[Effect of oxidative stress in patients with chronic renal failure]. Nefrologia (2006) 0.85
Thymoma associated with CD4+ lymphopenia, cytomegalovirus infection, and Kaposi's sarcoma. Hum Pathol (1997) 0.85
Carboplatin-gemcitabine treatment of patients with transitional cell carcinoma of the bladder and impaired renal function. Oncology (2000) 0.85
Prevalence of liver cell dysplasia and association with HCC in a series of 100 cirrhotic liver explants. J Hepatol (1997) 0.84
Modeling dynamic experiments on the anaerobic degradation of molasses wastewater. Biotechnol Bioeng (1988) 0.84
Benzodiazepine use in Chile: impact of availability on use, abuse, and dependence. J Clin Psychopharmacol (1996) 0.83
[Guidelines of the Spanish Society of Nephrology. Clinical practice guidelines for peritoneal dialysis]. Nefrologia (2006) 0.83
Feasiblity study of gemcitabine and cisplatin administered every two weeks in patients with advanced urothelial tumors and impaired renal function. Clin Transl Oncol (2006) 0.83
Eccrine porocarcinoma presenting with scrotal lymphedema: a case report and review of systemic treatment. Ann Oncol (2010) 0.82
Evidence of an increased susceptibility to lipid peroxidation in red blood cells of chronic renal failure patients. Nephron (1988) 0.82
Association of acromegaly and two malignancies: colorectal cancer and non-Hodgkin's lymphoma. Ann Oncol (1994) 0.81
Ectopic liver and hepatocarcinogenesis. Hepatology (1999) 0.81
[Helicobacter pylori and gastric cancer: relationship with histological subtype and tumor location]. Gastroenterol Hepatol (2005) 0.81
Adjuvant therapy with cetuximab for locally advanced squamous cell carcinoma of the oropharynx: results from a randomized, phase II prospective trial. Ann Oncol (2012) 0.81
Genetic variation in the population of Ibiza (Spain): genetic structure, geography, and language. Hum Biol (1996) 0.80
Impact of peritonitis on long-term survival of peritoneal dialysis patients. Nefrologia (2011) 0.80
Heterozygous protein C deficiency and dysfibrinogenemia acquired by liver transplantation. Transpl Int (1995) 0.80
Spanish delta-beta-thalassemia: hematological studies and composition of the gamma-chains in ten homozygous patients. Acta Haematol (1983) 0.80
Importance of residual renal function in continuous ambulatory peritoneal dialysis: its influence on different parameters of renal replacement treatment. Nephron (1999) 0.80
A surgical model for isolating the pig liver in vivo for gene therapy. Eur Surg Res (2013) 0.80
Red cell distribution width analysis in differentiation between iron deficiency and thalassemia minor. Acta Haematol (1988) 0.79
Bilateral testicular germ cell tumours: a single hospital experience. Clin Transl Oncol (2010) 0.79
Sepsis and SOFA score: related outcome for critically ill renal patients. Clin Nephrol (2004) 0.79
A dynamic analysis of the ventilatory response to carbon dioxide inhalation in man. J Physiol (1988) 0.79
Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study. Br J Cancer (2013) 0.79
A prospective multicenter comparison of peritonitis in peritoneal dialysis patients aged above and below 65 years. Levante PD Multicenter Group. Adv Perit Dial (2000) 0.79
[Diagnostic and therapeutic strategy in injuries of the kidney. Apropos of a series of 248 cases]. Ann Urol (Paris) (1988) 0.79
Cystic smooth-muscle tumor of the liver and spleen associated with Epstein-Barr virus after renal transplantation. Am J Surg Pathol (1996) 0.79
Assessment of abdominal sonography in the diagnosis of tumors of the gastroduodenal tract. J Clin Ultrasound (1997) 0.78
Phase II feasibility study of high dose epirubicin plus etoposide and cisplatin (HDEEC) regimen in small cell lung cancer. Invest New Drugs (1992) 0.78
[Analysis of survival in dialysis: hemodialysis versus peritoneal dialysis and the significance of comorbidity]. Nefrologia (2002) 0.78
Phase II study of estramustine and vinorelbine in hormone-refractory prostate carcinoma patients. Acta Oncol (1998) 0.78
[Fungal peritonitis episodes in a peritoneal dialysis centre during a 10-year period: a report of 11 cases]. Nefrologia (2005) 0.78
[Spontaneous rupture of the esophagus (Boerhaave syndrome) in a patient with scleroderma treated by continuous ambulatory peritoneal dialysis]. Rev Med Interne (1997) 0.78
Idiopathic myelofibrosis terminating in erythroleukemia. Am J Hematol (1989) 0.78
Case report: incomplete septal cirrhosis with liver cell dysplasia. J Gastroenterol Hepatol (1997) 0.78
Disagreement between hospital medical records and a structured patient interview on the type and date of the first symptom in cancers of the digestive tract. Rev Epidemiol Sante Publique (1995) 0.78
Human hair follicles may be used for population screening of heterozygotes of glucose-6-phosphate dehydrogenase deficiency. Clin Genet (1982) 0.77
[The automatic determination of organic acids by potentiometry]. Bull Soc Chim Biol (Paris) (1968) 0.77
[Automatic and simultaneous determination of amino acids and guanidines]. Bull Soc Chim Biol (Paris) (1970) 0.77
E400P in advanced seminoma of good prognosis according to the international germ cell cancer collaborative group (IGCCCG) classification: the Spanish Germ Cell Cancer Group experience. Ann Oncol (2001) 0.77
Phase II multicentre study of docetaxel plus cisplatin in patients with advanced urothelial cancer. Br J Cancer (2002) 0.77
Disseminated Mycobacterium avium infection after liver transplantation. Eur J Clin Microbiol Infect Dis (1998) 0.77
Agreement between CSF flow dynamics in MRI and ICP monitoring in the diagnosis of normal pressure hydrocephalus. Sensitivity and specificity of CSF dynamics to predict outcome. Acta Neurochir Suppl (2002) 0.77
A randomized study of intermediate as compared with high doses of interferon-alpha for chronic myeloid leukemia: no differences in cytogenetic responses. Ann Hematol (2003) 0.77
[Study of diastolic function in peritoneal dialysis patientes. Comparison between pulsed and Tissue Doppler]. Nefrologia (2007) 0.77
UFT plus or minus calcium folinate for metastatic colorectal cancer in older patients. Oncology (Williston Park) (1999) 0.76
Do patients with metastatic urothelial carcinoma benefit from docetaxel as second-line chemotherapy? Clin Transl Oncol (2013) 0.76
Cyclophosphamide and ifosfamide combination as neoadjuvant chemotherapy for locally advanced nonsmall-cell lung cancer: a meta-analytic review. J Surg Oncol (1990) 0.76
Morphology of hepatic stellate cells in patients with fulminant or subfulminant hepatitis requiring liver transplantation. J Submicrosc Cytol Pathol (1996) 0.76
Cholangiocarcinoma arising in Von Meyenburg complex associated with hepatocellular carcinoma in genetic haemochromatosis. Eur J Gastroenterol Hepatol (2000) 0.76
Extramedullary multiple myeloma. A qualitative and quantitative electron microscopic study. Virchows Arch B Cell Pathol Incl Mol Pathol (1982) 0.76
Multiple black hepatocellular adenomas in a male patient. Eur J Gastroenterol Hepatol (2000) 0.76
Phase I study of mitonafide in 120 hour continuous infusion in non-small cell lung cancer. Invest New Drugs (1992) 0.76
Central venous brachial catheter (P.A.S. Port TM) and catheter scanning system (Cath-Finder TM). J Surg Oncol (1994) 0.75
Angioimmunoblastic lymphadenopathy: treatment in three cases. Acta Haematol (1998) 0.75
Decreased survival of patients with lung cancer admitted to a teaching hospital through the emergency department in Barcelona, Spain. J Epidemiol Community Health (1998) 0.75
Pontine myelinolysis following liver transplantation: a report of two cases. Transpl Int (1993) 0.75
The suitability of saliva for detection of glucose-6-phosphate dehydrogenase deficiency. Mol Biol Rep (1988) 0.75
Cytomegalovirus infection and aplastic crisis in glucose-6-phosphate dehydrogenase deficiency. Lancet (1987) 0.75
Enzymatic polymorphisms in the Jewish community (Chuetas) from the Majorca Island. Gene Geogr (1990) 0.75
[Hypereosinophilic syndrome with an anomalous response to treatment with corticoids]. Sangre (Barc) (1985) 0.75
Bloody peritoneal fluid in a patient with tuberous sclerosis in a CAPD program. Perit Dial Int (1989) 0.75
Phosphoglycerate kinase deficiency: biochemical studies on hair follicles. J Clin Chem Clin Biochem (1986) 0.75
5-fluorouracil, ifosfamide and mitomycin (FIM) combination for pancreatic-biliary tumors. Ann Oncol (1991) 0.75
A phase II study of days 1 and 8 cisplatin and recombinant alpha-2B interferon in advanced non-small cell lung cancer. Cancer (1991) 0.75
[The description of a new cellular type, Pinocchio cells, induced during the treatment of solid tumors with interleukin-2]. Med Clin (Barc) (1990) 0.75